Immediate Impact
7 from Science/Nature 56 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Cancer cell metabolism and antitumour immunity
2024 Standout
Works of Ji‐Young Choe being referenced
Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
2014
Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer: Correlation with Fluorescence In Situ Hybridization
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ji‐Young Choe | 691 | 188 | 246 | 573 | 282 | 53 | 1.2k | |
| Julián Sanz‐Ortega | 594 | 280 | 340 | 475 | 406 | 70 | 1.4k | |
| Guidalberto Fabris | 571 | 113 | 137 | 319 | 225 | 46 | 1.2k | |
| Federica Zito Marino | 462 | 173 | 125 | 486 | 370 | 62 | 1.1k | |
| Serena Pedron | 347 | 224 | 232 | 776 | 589 | 47 | 1.5k | |
| Bradley G. Somer | 795 | 123 | 189 | 292 | 408 | 45 | 1.3k | |
| Brian Turpin | 498 | 136 | 225 | 737 | 355 | 53 | 1.4k | |
| Tomas Seidal | 388 | 133 | 263 | 450 | 331 | 59 | 1.2k | |
| Kitty Pavlakis | 501 | 214 | 166 | 297 | 567 | 80 | 1.6k | |
| Anuhya Kommalapati | 577 | 363 | 124 | 242 | 289 | 61 | 1.1k | |
| Ji‐Youn Sung | 462 | 342 | 181 | 292 | 390 | 87 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...